C.D.C. recommends second COVID-19 mRNA booster
A second COVID-19 immunization booster shot for adults at least 50-years-old is now available. The new recommendation from the U.S. Center for Disease Control and Prevention (C.D.C.) means more recipients of the mRNA vaccines manufactured by Pfizer-BioNTech and Moderna are now eligible for a fourth dose. C.D.C. clinicians recommend the fourth dose be administered four months after the first booster shot. “This is especially important for those 65 and older and those 50 and older with underlying medical conditions that increase their risk for severe disease from COVID-19 as they are the most likely to benefit from receiving an additional booster dose at this time,” said C.D.C. Director Rochelle P. Walensky. “C.D.C., in collaboration with [the U.S. Food and Drug Administration] and our public health partners, will continue to evaluate the need for additional booster doses for all Americans.” The Illinois Public Health Association continues its call for all Illinoisans to stay current with their COVID-19 vaccines to thwart the risk of serious illness and even hospitalization. Although reported cases are lower than they have been at any other point throughout the pandemic, COVID-19 has not been eradicated. To help Illinoisans maintain their vaccine status, an updated version of the COVID-19 vaccine guidelines has been updated for immediate use and distribution. A full directory of Community Health Workers able to aid those isolated or quarantined by COVID-19 is available online at helpguidethrive.org. The C.D.C. continues to maintain the vaccines.gov app that allows anyone to find a COVID-19 vaccine appointment.